SEC Tracker
Get the app

Transcode Therapeutics RNAZ

Transcode Therapeutics: reports quarterly results, sells unregistered shares and discloses other events

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Sells unregistered shares (3.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Transcode Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  2. LFTD Partners LIFD public float $6M, Jun 30, 2025
  3. Neuphoria Therapeutics NEUP public float $7M, Dec 31, 2025
  4. Sunshine Biopharma SBFM public float $7M, Jun 30, 2025
  5. Skinvisible SKVI public float $5M, Jun 30, 2025